CRT 2017 : FDA VALVE - Percutaenous Aortic Valves: Knowledge Gaps in a Maturing Technology

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

FDA VALVE - Percutaenous Aortic Valves: Knowledge Gaps in a Maturing Technology

Featuring

  • Michael Reardon
  • Raj Makkar
  • Jaime Raben
  • Michael Mack

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Beyond Strategy Trials: Are We Ready for OPCs? - Michael Reardon
Update to Valve Durability and Leaflet Thrombosis - Raj Makkar
Regulatory Pathways for New Indications - Jaime Raben
Extending the Boundaries of TAVR: Future Directions - Michael Mack

Target Audience

Learning Objectives

Related Moments

Percutaneous Treatment Of Coronary Chronic Total Occlusion Part 2: Technical Approach
Journal
Article on Percutaneous Treatment Of Coronary Chronic Total Occlusion Part 2: Technical Approach
The FUTURE Study - Scientific Review
Roundtable
FUTURE is a French open label, randomized clinical trial designed to test the superiority of FFR against angiography guided revascularization. Some of the early outcomes of the study were reported...
Supported By
CRT 2017: ACS & AMI Management - Things to Know
Conference
Loading Simple Education